Key Takeaways
- • A California appellate court is weighing whether private equity firms that acquire medical practice assets can fire physician owners who exercise independent clinical judgment, with implications for the corporate practice of medicine doctrine across the healthcare sector.
- • Private equity investment in physician practices has accelerated sharply: 484 PE-backed practices existed in 2021, representing a sixfold increase from 75 practices in 2012, creating heightened regulatory and legal scrutiny over physician autonomy and control.
- • The California Medical Association's amicus brief supports the lower court's finding that a "lay manager" structure improperly controlled clinical decision-making, arguing the century-old corporate practice of medicine law must be applied with precision to prevent unintended consequences in healthcare.
- • The Art Center Holdings case centers on a PE firm's demand that a physician-owner terminate two employee physicians; when the owner refused, the PE firm fired the physician-owner, triggering a receivership order now under appeal.
- • Recent data shows physician attrition accelerates after PE exits: physicians are 16.5 percentage points more likely to leave within two years following a PE-backed practice sale compared to non-PE practices, with only 44% retention versus 60% at comparable non-PE practices.
Summary
A significant legal battle over physician autonomy and private equity control of medical practices is reaching the California Court of Appeal, with potential implications across the broader healthcare investment landscape. The case, Art Center Holdings Inc. et al v. WCE CA Art LLC et al., stems from a dispute in which a private equity firm demanded that a physician-owner terminate two employee physicians. When the physician-owner refused to comply—exercising independent clinical judgment—the PE firm proceeded to fire the physician-owner. This sequence triggered a Los Angeles Superior Court finding that a corporate structure ostensibly designed as a "friendly professional corporation" had resulted in lay managers improperly controlling clinical aspects of medical practice operations, leading to a receivership order.
The California Medical Association filed an amicus brief that does not directly address the receivership appeal but instead reinforces the lower court's core finding: that nonphysician entities cannot lawfully control clinical decision-making without violating California's corporate practice of medicine statute, a century-old law designed to protect physician independence. The CMA argues this statute "must be applied with precision" to avoid unintended consequences as the healthcare industry continues to evolve. This framing establishes a critical precedent regarding the boundaries of PE influence over medical practice operations and physician employment decisions tied to clinical judgment.
The case arrives amid a dramatic expansion of PE activity in physician practices. Data shows private equity firms invested in 484 physician practices in 2021, representing a sixfold increase from just 75 practices in 2012. This influx has intensified questions about whether PE ownership structures adequately protect physician independence and patient care quality. Recent research reinforces these concerns: a JAMA Health Forum study found that physicians are 16.5 percentage points more likely to leave within two years following a PE-backed practice sale, with only 44% retention compared to 60% at comparable non-PE practices. This volatility suggests that PE exits and operational control disputes create substantial physician workforce instability.
For institutional investors and fund managers with PE healthcare holdings, the Art Center Holdings decision carries material implications. A ruling that restricts PE firms' ability to control clinical employment decisions could narrow operational control levers in medical practice investments, potentially affecting deal structures, management authority, and exit strategies. Conversely, a ruling supporting PE authority could solidify PE acquisition models but may invite further regulatory scrutiny. The case underscores broader tension between financial returns and physician autonomy—a central issue in PE healthcare investing as the sector has grown to encompass hundreds of practices across multiple specialties.
The California Medical Association filed an amicus brief that does not directly address the receivership appeal but instead reinforces the lower court's core finding: that nonphysician entities cannot lawfully control clinical decision-making without violating California's corporate practice of medicine statute, a century-old law designed to protect physician independence. The CMA argues this statute "must be applied with precision" to avoid unintended consequences as the healthcare industry continues to evolve. This framing establishes a critical precedent regarding the boundaries of PE influence over medical practice operations and physician employment decisions tied to clinical judgment.
The case arrives amid a dramatic expansion of PE activity in physician practices. Data shows private equity firms invested in 484 physician practices in 2021, representing a sixfold increase from just 75 practices in 2012. This influx has intensified questions about whether PE ownership structures adequately protect physician independence and patient care quality. Recent research reinforces these concerns: a JAMA Health Forum study found that physicians are 16.5 percentage points more likely to leave within two years following a PE-backed practice sale, with only 44% retention compared to 60% at comparable non-PE practices. This volatility suggests that PE exits and operational control disputes create substantial physician workforce instability.
For institutional investors and fund managers with PE healthcare holdings, the Art Center Holdings decision carries material implications. A ruling that restricts PE firms' ability to control clinical employment decisions could narrow operational control levers in medical practice investments, potentially affecting deal structures, management authority, and exit strategies. Conversely, a ruling supporting PE authority could solidify PE acquisition models but may invite further regulatory scrutiny. The case underscores broader tension between financial returns and physician autonomy—a central issue in PE healthcare investing as the sector has grown to encompass hundreds of practices across multiple specialties.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.